Profile data is unavailable for this security.
About the company
Biosynex SA is a France-based company that specializes in the research, development and manufacture of in-vitro diagnostic kits aimed at health professionals. The Company’s products are used by biological and analytical services laboratories, obstetric units and emergency units, as well as in medical resource-limited settings. Biosynex SA specializes in four fields: tropical diseases, emergency markers, infectious diseases and autoimmunity. The Company’s products include Amnioquick (Obstetrics); Immunoquick Malaria Falciparum and Immunoquick Malaria +4 (Parasitology); Immunoquick Elifa HSV IGG, Immunoquick Elifa EBV G and Immunoquick Mono (Virology); Immunoquick Filtration CELIAC IgA and Immunoquick TG (Autoimmunology); and Immunoquick Tetanus (Bacteriology). It operates through Fumouze Diagnostics and SR2B.
- Revenue in EUR (TTM)92.98m
- Net income in EUR-37.12m
- Incorporated2005
- Employees575.00
- LocationBiosynex SA22 Boulevard Sebastien BrantILLKIRCH-GRAFFENSTADEN 67400FranceFRA
- Phone+33 388787887
- Fax+33 388787678
- Websitehttps://www.biosynex.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alpha Mos SA | 4.51m | -4.74m | 10.01m | 53.00 | -- | -- | -- | 2.22 | -0.4345 | -0.4345 | 0.4127 | -0.7428 | 0.599 | 2.93 | 7.36 | 85,000.00 | -63.06 | -47.80 | -521.78 | -139.09 | 45.55 | 68.00 | -105.28 | -68.64 | 0.2498 | -7.77 | -- | -- | -22.46 | 4.97 | -76.91 | -- | -18.75 | -- |
| Bluelinea SA | 9.83m | -1.62m | 10.35m | 86.00 | -- | 3.85 | 86.41 | 1.05 | -0.1319 | -0.1319 | 0.8002 | 0.2185 | 0.8187 | 0.2581 | 7.00 | 114,260.40 | -13.49 | -26.29 | -28.47 | -58.29 | 99.25 | 92.43 | -16.48 | -29.24 | 0.5362 | -32.47 | 0.5757 | -- | -5.59 | 9.78 | -4.91 | -- | 20.53 | -- |
| Aton SA | 1.56k | -563.57k | 10.58m | 17.00 | -- | -- | -- | 6,784.85 | -0.0021 | -0.0021 | 0.00001 | -- | -- | -- | -- | -- | -- | -47.55 | -- | -60.70 | -23,780.77 | -- | -36,126.28 | -3,320.95 | -- | -- | -- | -- | 24,396.79 | 37.77 | -3,244.13 | -- | -- | -- |
| Implanet SA | 7.30m | -6.91m | 13.62m | 41.00 | -- | 4.07 | -- | 1.87 | -0.1305 | -0.1226 | 0.0979 | 0.028 | 0.5227 | 0.7927 | 3.83 | 179,262.90 | -49.48 | -37.44 | -111.96 | -86.74 | 55.22 | 59.59 | -94.67 | -67.43 | 0.5906 | -14.51 | 0.5671 | -- | -7.24 | 2.08 | -88.59 | -- | -2.20 | -- |
| Laboratoires Euromedis SA | 34.04m | 13.11m | 14.64m | 54.00 | 1.13 | 0.6583 | 1.10 | 0.4302 | 4.60 | 4.60 | 11.66 | 7.93 | 0.6415 | 3.05 | 3.92 | 630,347.60 | 24.71 | 8.76 | 34.65 | 12.45 | 0.5338 | 15.57 | 38.52 | 6.10 | 1.46 | -26.38 | 0.3031 | -- | -37.18 | -- | 320.97 | -- | -- | -- |
| Theraclion SA | 1.82m | -3.68m | 15.05m | 29.00 | -- | 3.32 | -- | 8.26 | -0.0811 | -0.0811 | 0.0397 | 0.1236 | 0.1118 | 0.1081 | 0.6807 | 62,835.52 | -22.54 | -32.98 | -30.99 | -48.01 | 81.88 | 60.85 | -201.68 | -249.16 | 2.86 | -40.63 | 0.2564 | -- | 47.49 | -1.13 | 25.97 | -- | -7.23 | -- |
| Intrasense SA | 3.31m | -3.58m | 15.27m | 74.00 | -- | 2.01 | -- | 4.62 | -0.0697 | -0.0697 | 0.0644 | 0.1396 | 0.3897 | -- | 4.06 | 44,662.16 | -42.20 | -29.51 | -58.14 | -43.12 | 89.08 | 87.59 | -108.29 | -54.42 | -- | -32.28 | 0.1697 | -- | -12.80 | 1.53 | -4.65 | -- | -- | -- |
| Ikonisys SA | 448.56k | -2.27m | 16.51m | 10.00 | -- | 1.02 | -- | 36.81 | -0.233 | -0.233 | 0.0461 | 1.62 | 0.0211 | 1.18 | 32.21 | 44,856.00 | -10.65 | -- | -12.50 | -- | -20.88 | -- | -505.54 | -- | 0.0619 | -29.68 | 0.1244 | -- | -27.28 | -- | 7.38 | -- | -- | -- |
| Diagnostic Medical Systems SA | 42.15m | -9.76m | 17.11m | 147.00 | -- | 1.38 | -- | 0.4059 | -0.4982 | -0.2481 | 2.23 | 0.7023 | 0.8027 | 1.81 | 6.81 | 286,755.10 | -18.73 | -12.33 | -33.53 | -22.14 | 37.58 | 37.72 | -23.33 | -16.45 | 0.7105 | -3.52 | 0.5938 | -- | 19.51 | 11.62 | -106.30 | -- | -- | -- |
| Mauna Kea Technologies SA | 10.48m | -3.73m | 21.54m | 68.00 | -- | -- | -- | 2.06 | -0.0578 | -0.0578 | 0.2126 | -0.2809 | 0.4905 | 2.31 | 2.45 | 154,117.60 | -17.45 | -51.23 | -223.84 | -93.30 | 33.62 | 11.15 | -35.57 | -142.41 | 0.4287 | 4.29 | 2.38 | -- | 40.13 | 9.16 | 66.66 | -- | -21.16 | -- |
| Global Bioenergies SA | 486.33k | -7.36m | 27.86m | 46.00 | -- | -- | -- | 57.29 | -0.4036 | -0.4036 | 0.0267 | -0.0081 | 0.0276 | 2.74 | 0.1188 | 10,572.39 | -41.78 | -43.66 | -99.83 | -82.47 | -600.24 | -948.35 | -1,513.81 | -1,331.36 | 0.8447 | -- | -- | -- | 365.83 | 36.25 | 27.78 | -- | -19.49 | -- |
| AbL Diagnostics SA | 5.61m | 54.36k | 44.40m | 19.00 | 860.53 | 6.90 | 61.96 | 7.91 | 0.0034 | 0.0034 | 0.3483 | 0.42 | 0.3703 | -- | 1.42 | 295,411.60 | 0.3587 | 3.24 | 0.5884 | 4.43 | -- | -- | 0.9685 | 8.81 | 1.87 | -47.51 | 0.3389 | -- | -35.84 | 74.86 | -95.08 | -49.30 | -- | -- |
| Biosynex SA | 92.98m | -37.12m | 44.53m | 575.00 | -- | 0.3482 | -- | 0.4789 | -3.64 | -3.64 | 9.10 | 11.92 | 0.3704 | 1.16 | 7.34 | 161,700.90 | -14.18 | 14.90 | -17.51 | 19.41 | 52.84 | 51.92 | -38.30 | 14.61 | 1.03 | -28.00 | 0.3459 | -- | -52.70 | 24.40 | -337.76 | -- | -- | -- |
Data as of Sep 30 2024. Currency figures normalised to Biosynex SA's reporting currency: Euro EUR
1.10%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Sunny Asset Management SAas of 25 Jul 2024 | 75.00k | 0.70% |
| Mandarine Gestion SAas of 14 Sep 2023 | 41.01k | 0.38% |
| American Century Investment Management, Inc.as of 03 Jul 2024 | 2.42k | 0.02% |
| Financi�re Arbevel SAas of 30 Dec 2022 | 0.00 | 0.00% |
| MCA Finance SAas of 29 Dec 2023 | 0.00 | 0.00% |
| Lazard Asset Management LLCas of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 29 Dec 2023 - 25 Jul 2024Source: FactSet Research Systems Inc.
